{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:00:14Z","timestamp":1788184814909,"version":"build-2803163510"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007687","name":"Swedish Society of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007436","name":"Erling Persson Family Foundation","doi-asserted-by":"publisher","award":["140609"],"award-info":[{"award-number":["140609"]}],"id":[{"id":"10.13039\/100007436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009336","name":"Bengt Ihres Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.clnu.2026.106584","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:18:25Z","timestamp":1769213905000},"page":"106584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Bariatric surgery improves fibrinolysis in individuals with obesity with and without concomitant type 2 diabetes"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6764-3435","authenticated-orcid":false,"given":"Maja","family":"Andersson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Thorell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Henriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Kallner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5kan","family":"Wall\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas L.","family":"Lindahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"\u00c5gren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2026.106584_bib1","series-title":"Obesity and overweight","year":"2024"},{"key":"10.1016\/j.clnu.2026.106584_bib2","series-title":"Diabetes facts and figures","year":"2024"},{"issue":"1","key":"10.1016\/j.clnu.2026.106584_bib3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/1479164116675488","article-title":"Vascular risk in obesity: facts, misconceptions and the unknown","volume":"14","author":"King","year":"2017","journal-title":"Diabetes Vasc Dis Res"},{"issue":"21","key":"10.1016\/j.clnu.2026.106584_bib4","doi-asserted-by":"crossref","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","article-title":"Obesity and cardiovascular disease: a scientific statement from the American Heart Association","volume":"143","author":"Powell-Wiley","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.clnu.2026.106584_bib5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","article-title":"Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017","volume":"17","author":"Einarson","year":"2018","journal-title":"Cardiovasc Diabetol"},{"issue":"10085","key":"10.1016\/j.clnu.2026.106584_bib6","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/S0140-6736(17)30058-2","article-title":"Type 2 diabetes","volume":"389","author":"Chatterjee","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.clnu.2026.106584_bib7","first-page":"85","article-title":"Blood coagulation and fibrinolysis in obese NIDDM patients","volume":"25","author":"Avellone","year":"1994","journal-title":"Diabetes Res"},{"key":"10.1016\/j.clnu.2026.106584_bib8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.phrs.2017.04.009","article-title":"Targeting endothelial metaflammation to counteract diabesity cardiovascular risk: current and perspective therapeutic options","volume":"120","author":"Potenza","year":"2017","journal-title":"Pharmacol Res"},{"issue":"1","key":"10.1016\/j.clnu.2026.106584_bib9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12933-021-01372-w","article-title":"Hypofibrinolysis in type 2 diabetes and its clinical implications: from mechanisms to pharmacological modulation","volume":"20","author":"Bryk-Wi\u0105zania","year":"2021","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"10.1016\/j.clnu.2026.106584_bib10","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/meta.2002.31334","article-title":"Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: association with increased plasminogen activator inhibitor-1","volume":"51","author":"Aso","year":"2002","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.clnu.2026.106584_bib11","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1665-2681(19)31746-6","article-title":"Altered clot kinetics in patients with non-alcoholic fatty liver disease","volume":"8","author":"Hickman","year":"2009","journal-title":"Ann Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.clnu.2026.106584_bib12","first-page":"78","article-title":"Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity","volume":"32","author":"Juhan-Vague","year":"2000","journal-title":"Ann Med"},{"issue":"7","key":"10.1016\/j.clnu.2026.106584_bib13","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/ehjcvp\/pvae064","article-title":"Update on antithrombotic therapy and body mass: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and the European Society of Cardiology Working Group on Thrombosis","volume":"10","author":"Gigante","year":"2024","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"1","key":"10.1016\/j.clnu.2026.106584_bib14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12933-017-0515-9","article-title":"Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk","volume":"16","author":"Kearney","year":"2017","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"10.1016\/j.clnu.2026.106584_bib15","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/jamasurg.2016.2317","article-title":"Bariatric surgery and long-term durability of weight loss","volume":"151","author":"Maciejewski","year":"2016","journal-title":"JAMA Surg"},{"issue":"1","key":"10.1016\/j.clnu.2026.106584_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijcard.2014.02.026","article-title":"Bariatric surgery and its impact on cardiovascular disease and mortality: a systematic review and meta-analysis","volume":"173","author":"Kwok","year":"2014","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.clnu.2026.106584_bib17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.2011.1914","article-title":"Bariatric surgery and long-term cardiovascular events","volume":"307","author":"Sj\u00f6str\u00f6m","year":"2012","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.clnu.2026.106584_bib18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7570\/jomes20084","article-title":"Preoperative bariatric surgery predictors of type 2 diabetes remission","volume":"30","author":"Fultang","year":"2021","journal-title":"J Obes Metab Syndr"},{"issue":"4","key":"10.1016\/j.clnu.2026.106584_bib19","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1055\/s-0040-1702224","article-title":"Effects of obesity surgery on blood coagulation and fibrinolysis: a literature review","volume":"120","author":"Bladbjerg","year":"2020","journal-title":"Thromb Haemost"},{"issue":"8","key":"10.1016\/j.clnu.2026.106584_bib20","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.soard.2016.03.020","article-title":"Improved glucose metabolism after gastric bypass: evolution of the paradigm","volume":"12","author":"Pournaras","year":"2016","journal-title":"Surg Obes Relat Dis"},{"issue":"6","key":"10.1016\/j.clnu.2026.106584_bib21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000442721","article-title":"European guidelines for obesity management in adults","volume":"8","author":"Yumuk","year":"2015","journal-title":"Obes Facts"},{"key":"10.1016\/j.clnu.2026.106584_bib22","series-title":"Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus: abbreviated report of a WHO consultation","year":"2011"},{"issue":"4","key":"10.1016\/j.clnu.2026.106584_bib23","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00268-021-06394-9","article-title":"Guidelines for perioperative care in bariatric surgery: Enhanced Recovery After Surgery (ERAS) society recommendations: a 2021 update","volume":"46","author":"Stenberg","year":"2022","journal-title":"World J Surg"},{"issue":"3","key":"10.1016\/j.clnu.2026.106584_bib24","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1055\/s-0038-1651028","article-title":"Blood collection in strong acidic citrate anticoagulant used in a study of dietary influence on basal tPA activity","volume":"62","author":"R\u00e5nby","year":"1989","journal-title":"Thromb Haemost"},{"issue":"10","key":"10.1016\/j.clnu.2026.106584_bib25","doi-asserted-by":"crossref","first-page":"e3193","DOI":"10.1210\/clinem\/dgaf092","article-title":"Influence of bariatric surgery on endothelial and glycocalyx biomarkers in obesity and type 2 diabetes","volume":"110","author":"Andersson","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clnu.2026.106584_bib26","series-title":"Biostatistical analysis","author":"Zar","year":"2010"},{"key":"10.1016\/j.clnu.2026.106584_bib27","series-title":"Multi- and megavariate data analysis: part I: basic principles and applications","author":"Eriksson","year":"2006"},{"key":"10.1016\/j.clnu.2026.106584_bib28","series-title":"Multi- and megavariate data analysis: part II: advanced applications and method extension","author":"Eriksson","year":"2006"},{"issue":"6","key":"10.1016\/j.clnu.2026.106584_bib29","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1182\/blood-2018-07-818211","article-title":"The multifaceted role of fibrinogen in tissue injury and inflammation","volume":"133","author":"Luyendyk","year":"2019","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clnu.2026.106584_bib30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/cvr\/cvad017","article-title":"Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice","volume":"119","author":"Z\u0105bczyk","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"10","key":"10.1016\/j.clnu.2026.106584_bib31","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1161\/01.ATV.0000242905.41404.68","article-title":"PAI-1 and the metabolic syndrome: links, causes, and consequences","volume":"26","author":"Alessi","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.clnu.2026.106584_bib32","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1161\/01.ATV.0000062885.61917.A5","article-title":"Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy","volume":"23","author":"Yki-J\u00e4rvinen","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"13","key":"10.1016\/j.clnu.2026.106584_bib33","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1182\/blood-2004-04-1439","article-title":"Platelets synthesize large amounts of active plasminogen activator inhibitor 1","volume":"104","author":"Brogren","year":"2004","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.clnu.2026.106584_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026762","article-title":"Platelets retain high levels of active plasminogen activator inhibitor 1","volume":"6","author":"Brogren","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.clnu.2026.106584_bib35","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1148\/radiol.2018181134","article-title":"Monitoring fatty liver disease with MRI following bariatric surgery: a prospective, dual-center Study","volume":"290","author":"Pooler","year":"2019","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.clnu.2026.106584_bib36","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/00365519850186274","article-title":"Tissue plasminogen activator (tPA) antigen in plasma: correlation with different tPA\/inhibitor complexes","volume":"58","author":"Nordenhem","year":"1998","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.clnu.2026.106584_bib37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1475-2840-2-19","article-title":"High levels of tissue plasminogen activator (tPA) antigen precede the development of type 2 diabetes in a longitudinal population study. The Northern Sweden MONICA study","volume":"2","author":"Eliasson","year":"2003","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.clnu.2026.106584_bib38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1475-2840-10-23","article-title":"Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects","volume":"10","author":"Al-Hamodi","year":"2011","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"10.1016\/j.clnu.2026.106584_bib39","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1203\/01.PDR.0000164307.92308.09","article-title":"Plasminogen activator inhibitor-1 and tissue-plasminogen activator in minority adolescents with type 2 diabetes and obesity","volume":"58","author":"Umpaichitra","year":"2005","journal-title":"Pediatr Res"},{"issue":"11","key":"10.1016\/j.clnu.2026.106584_bib40","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.amjcard.2014.08.046","article-title":"Effect of obesity on acute hemostatic responses to live-fire training drills","volume":"114","author":"Smith","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clnu.2026.106584_bib41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.thromres.2022.03.013","article-title":"Associations between hemostatic markers and mortality in COVID-19 - compounding effects of D-dimer, antithrombin and PAP complex","volume":"213","author":"Bokn\u00e4s","year":"2022","journal-title":"Thromb Res"},{"issue":"7","key":"10.1016\/j.clnu.2026.106584_bib42","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S1357-2725(99)00032-1","article-title":"Fibrinogen","volume":"31","author":"Herrick","year":"1999","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"10.1016\/j.clnu.2026.106584_bib43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0030-1248720","article-title":"Fibrinogen and the risk of thrombosis","volume":"36","author":"de Moerloose","year":"2010","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"10.1016\/j.clnu.2026.106584_bib44","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s12288-011-0116-9","article-title":"A study of plasma fibrinogen level in type-2 diabetes mellitus and its relation to glycemic control","volume":"28","author":"Bembde","year":"2012","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"Suppl A","key":"10.1016\/j.clnu.2026.106584_bib45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/eurheartj\/16.suppl_A.21","article-title":"Epidemiology of fibrinogen","volume":"16","author":"Folsom","year":"1995","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.clnu.2026.106584_bib46","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.47391\/JPMA.10403","article-title":"Correlation between plasma fibrinogen levels and microvascular complications in type 2 diabetes","volume":"74","author":"Ahmad","year":"2024","journal-title":"J Pakistan Med Assoc"},{"issue":"2","key":"10.1016\/j.clnu.2026.106584_bib47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/1479164112451588","article-title":"Fibrinogen and future cardiovascular disease in people with diabetes: aetiological associations and risk prediction using individual participant data from nine community-based prospective cohort studies","volume":"10","author":"Kengne","year":"2013","journal-title":"Diabetes Vasc Dis Res"},{"issue":"1","key":"10.1016\/j.clnu.2026.106584_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-64582-8","article-title":"Ramadan intermittent fasting is associated with improved anticoagulant activity among healthy people: a case-control study","volume":"14","author":"Al-Ghumlas","year":"2024","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.clnu.2026.106584_bib49","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1055\/s-0040-1718923","article-title":"Fibrinolysis in acute and chronic cardiovascular disease","volume":"47","author":"Kietsiriroje","year":"2021","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"10.1016\/j.clnu.2026.106584_bib50","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1055\/s-0038-1650330","article-title":"The significance of hypofibrinolysis for the risk of recurrence of venous thromboembolism. Duration of Anticoagulation (DURAC) trial study group","volume":"75","author":"Schulman","year":"1996","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1016\/j.clnu.2026.106584_bib51","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1055\/s-0041-1725094","article-title":"Fibrinolysis in venous thromboembolism","volume":"47","author":"Undas","year":"2021","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"10.1016\/j.clnu.2026.106584_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100081","article-title":"Fibrinolysis: an illustrated review","volume":"7","author":"Risman","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"issue":"5","key":"10.1016\/j.clnu.2026.106584_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052721","article-title":"A narrative review on plasminogen activator Inhibitor-1 and its (patho)Physiological role: to target or not to target?","volume":"22","author":"Sillen","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"Suppl 1","key":"10.1016\/j.clnu.2026.106584_bib54","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1538-7836.2007.02519.x","article-title":"Fibrin and fibrinolysis in infection and host defense","volume":"5","author":"Degen","year":"2007","journal-title":"J Thromb Haemostasis"},{"issue":"4","key":"10.1016\/j.clnu.2026.106584_bib55","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1055\/s-0039-1688495","article-title":"Fibrin and fibrinolysis in cancer","volume":"45","author":"Kwaan","year":"2019","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"10.1016\/j.clnu.2026.106584_bib56","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/acel.12601","article-title":"Molecular and physiological manifestations and measurement of aging in humans","volume":"16","author":"Khan","year":"2017","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.clnu.2026.106584_bib57","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1186\/s12964-024-01910-5","article-title":"A signaling pathway map of plasminogen activator inhibitor-1 (PAI-1\/SERPINE-1): a review of an innovative frontier in molecular aging and cellular senescence","volume":"22","author":"Shaikh","year":"2024","journal-title":"Cell Commun Signal"},{"issue":"7","key":"10.1016\/j.clnu.2026.106584_bib58","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1473-3099(06)70523-0","article-title":"Obesity and infection","volume":"6","author":"Falagas","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clnu.2026.106584_bib59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejim.2021.03.031","article-title":"Obesity as an adipose tissue dysfunction disease and a risk factor for infections - Covid-19 as a case study","volume":"91","author":"Landecho","year":"2021","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.1016\/j.clnu.2026.106584_bib60","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnz014","article-title":"Review: diabetes, obesity, and cancer-pathophysiology and clinical implications","volume":"41","author":"Lega","year":"2020","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1016\/j.clnu.2026.106584_bib61","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/ije\/dyaa099","article-title":"Higher risk of dementia in English older individuals who are overweight or obese","volume":"49","author":"Ma","year":"2020","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.clnu.2026.106584_bib62","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.14.04067","article-title":"Role of body mass index and weight change in the risk of cancer: a systematic review and meta-analysis of 66 cohort studies","volume":"14","author":"Shi","year":"2024","journal-title":"J Glob Health"},{"issue":"7","key":"10.1016\/j.clnu.2026.106584_bib63","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1161\/01.ATV.0000077401.36885.BB","article-title":"Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation","volume":"23","author":"Alessi","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.clnu.2026.106584_bib64","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-0038-1650524","article-title":"Liver steatosis and its relation to plasma haemostatic factors in apparently healthy men--role of the metabolic syndrome","volume":"76","author":"Cigolini","year":"1996","journal-title":"Thromb Haemost"},{"issue":"10390","key":"10.1016\/j.clnu.2026.106584_bib65","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/S0140-6736(23)00634-7","article-title":"Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial","volume":"401","author":"Verrastro","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.clnu.2026.106584_bib66","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s00423-024-03422-9","article-title":"Long-term prevalence of vitamin deficiencies after bariatric surgery: a meta-analysis","volume":"409","author":"Chen","year":"2024","journal-title":"Langenbecks Arch Surg"},{"issue":"8","key":"10.1016\/j.clnu.2026.106584_bib67","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1007\/s11695-019-03926-0","article-title":"Effect of bariatric surgery on serum inflammatory factors of Obese patients: a systematic review and meta-analysis","volume":"29","author":"Askarpour","year":"2019","journal-title":"Obes Surg"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561426000117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561426000117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:57:19Z","timestamp":1777532239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561426000117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":67,"alternative-id":["S0261561426000117"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2026.106584","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bariatric surgery improves fibrinolysis in individuals with obesity with and without concomitant type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2026.106584","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106584"}}